Annual Drug Patent Expirations for PROAIR+RESPICLICK
Proair Respiclick is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are fifteen patents protecting this drug.
Drug patent litigation for PROAIR RESPICLICK.
This drug has two hundred and sixty-two patent family members in thirty-one countries.
The generic ingredient in PROAIR RESPICLICK is albuterol sulfate. Two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
